Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Wound Dressing Hyaluronic Acid
Ingredient: Hyaluronic, Glycerin, Trehalose, Disodium hydrogen phosphate, Sodium dihydrogen phosphate and purified water
Specification: 25g
Package: Bag
Application Area: Daily maintenance, wound protection after injection.
Product Introduction：
Gentle yet effective hydration for everyday skincare and post-treatment recovery. Ensures high-purity HA content, sterile and preservative-free, safe for facial procedures and wound protection. Hyaluronic acid fillers are well-tolerated across different skin types and tones, making them a suitable treatment option for a wide range of patients.
Product Display：
Product Details:
Type | |
Specification | 25g |
Application area | Skin surface |
Ingredient | Hyaluronic, glycerin, trehalose, disodium hydrogen phosphate, sodium dihydrogen phosphate and purified water |
Product efficacy | Daily maintenance, wound protection after injection |
How to choose | For young skin |
Package | Bag package, Sterile |
Storage | Room temperature (1-25ºC), cool and dry place |
Recommended | 1pc/time |
Lasting time | 24 hours |
Heavy metal residue | ≤10μg/g |
Endotoxin content | <0.5EU/mL |
Product Package:
Customer Feedback：
Raw Material Advantages：
1. Unlike collagen-based fillers, which may require allergy testing before treatment, hyaluronic acid fillers do not necessitate pre-treatment testing, streamlining the patient experience.
2. Because hyaluronic acid is naturally found in the body, fillers made from this substance integrate seamlessly with the surrounding tissues, producing a more natural feel and look.
Development Process:
Company Introduction:
With an in-depth understanding of the medical device industry, our team, which has collaborated for over 15 years, has successfully transformed complex medical materials into market-ready solutions. The company has achieved significant milestones, including securing a Class III device registration certificate and advancing eight high-value devices with market sales surpassing one billion yuan into the clinical registration phase.
